Tetralogy of Fallot (TOF) is a complex congenital heart defect.
Patients with TOF often exhibit significant physiological challenges.
Understanding associated complications is crucial for patient management.
Purpose:
To investigate the prevalence and potential causes of hemostatic disturbances in patients with Tetralogy of Fallot.
To explore the pathogenetic mechanisms underlying these hemostatic abnormalities.
Summary:
A high incidence (62%) of hemostatic disturbances was observed in patients with Tetralogy of Fallot.
Potential contributing factors include chronic consumption coagulopathy, impaired reticuloendothelial system (RES) function, and hypoxia-induced effects on hemostasis and thrombocytopoiesis.
Impact:
Highlights the significant risk of bleeding or clotting complications in TOF patients.
Informs clinical practice regarding the need for careful hemostatic assessment and management in TOF.
Suggests avenues for further research into the specific mechanisms of hemostasis disruption in congenital heart disease.